RxDoctor Payments Data

Scott Cordray, DO

Otolaryngology · Tulsa, OKNPI 1982693396

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for otolaryngology clinicians in OK, where the typical reported total is $1,028.

$58in general payments, 2019–2025

Across 3 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$30
  • Medtronic$28
$319,156in research payments, 2019–2025

Across 134 payments — averaging $2381.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$155K
  • Sanofi US Services Inc.$120K
  • Insmed, Inc.$44K

What the payments were for

  • Food & beverage$58100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker1$30
Medtronic2$28

How this compares

$58 in reported general payments places this provider in the 5th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$192,449
Medicare patients
156
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$47,917
Fluticasone Propionate58$1,400
CefuroximeCefuroxime Axetil38$996
Ipratropium Bromide34$823
Azelastine Hcl32$717
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$404
Montelukast Sodium30$302
Cephalexin43$263
Mupirocin32$240
Ibuprofen11$138
Prednisone24$31

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →